The POT1 (protection of telomeres) protein binds the single-stranded G-rich overhang and is essential for both telomere end protection and telomere length regulation. Telomeric binding of POT1 is enhanced by its interaction with TPP1. In this study, we demonstrate that mouse Tpp1 confers telomere end protection by recruiting Pot1a and Pot1b to telomeres. Knockdown of Tpp1 elicits a p53-dependent growth arrest and an ATM-dependent DNA damage response at telomeres. In contrast to depletion of Trf2, which activates ATM, removal of Pot1a and Pot1b from telomeres initiates an ATR-dependent DNA damage response (DDR). Finally, we show that telomere dysfunction as a result of Tpp1 depletion promotes chromosomal instability and tumorigenesis in the absence of an ATMdependent DDR. Our results uncover a novel ATR-dependent DDR at telomeres that is normally shielded by POT1 binding to the single-stranded G-overhang. In addition, our results suggest that loss of ATM can cooperate with dysfunctional telomeres to promote cellular transformation and tumor formation in vivo.
Introduction
Telomeres are specialized DNA-protein complexes that cap the ends of eukaryotic chromosomes and play crucial roles in ensuring genomic stability by providing both end protection and a mechanism for maintenance of chromosomal ends. Mammalian telomeres consist of TTAGGG repetitive duplex sequences that terminate in single-stranded 3 0 G-rich overhangs that can be sequestered into lariat-like structures termed the t-loop (Griffith et al, 1999; de Lange, 2004 ). This structure is postulated to protect natural DNA ends from being recognized as double-strand breaks (DSBs). In most eukaryotes, telomeres are maintained by the enzyme telomerase, a specialized reverse transcriptase that adds telomeric DNA to the 3 0 ends of telomeres. Telomerase is limiting in human somatic cells, leading to telomere attrition with each round of DNA replication. Failure to properly maintain telomere functions results in dysfunctional telomeres that initiate the onset of replicative senescence or fuel genomic instability to promote tumorigenesis Wong et al, 2006) .
Telomeres are protected by a complex of six core proteins composed of TRF1, TRF2, RAP1, TIN2, TPP1 and POT1 (de Lange, 2005) . This complex, termed shelterin, serves to protect telomeres from being recognized as DSBs and inappropriate repair by the non-homologous end joining (NHEJ) and homologous recombination (HR) pathways.
Three sequence-specific DNA-binding proteins are recruited to chromosomal ends: TRF1 and TRF2 bind double-stranded telomeric DNA, while POT1 binds the single-stranded 3 0 overhang. POT1 homologs have been identified in most eukaryotes. All POT1 proteins examined to date contain two highly conserved oligonucleotide/oligosaccharide-binding folds (OB folds) that bind to the 3 0 terminus of the singlestranded G-rich telomeric overhang. In accord with its end protective function, deletion of POT1 results in chromosomal end-to-end fusions. In addition, removal of vertebrate POT1 does not result in overhang loss, but rather elicits a DNA damage response (DDR) at telomeres. The two Pot1 proteins in mice (Pot1a and Pot1b) appear to have distinct functionsgene knockout of Pot1a elicits a DDR at telomeres, elevated chromosomal fusions and aberrant HR at telomeres (Hockemeyer et al, 2006; Wu et al, 2006) , while knockout of Pot1b leads to elongated G-overhangs (Hockemeyer et al, 2006) .
TPP1 forms a heterodimer with POT1, and this cooperative interaction greatly increases the affinity of POT1 for its substrate DNA (Wang et al, 2007; Xin et al, 2007) . TPP1 also appears to play a crucial role in the proper assembly of the shelterin complex. TPP1 and POT1 are linked to TRF1 and TRF2 through TPP1's interaction with TIN2 (Houghtaling et al, 2004; Kim et al, 2004; Liu et al, 2004a, b; Ye et al, 2004a, b; Yang et al, 2005 ; O' Connor et al, 2006) . In addition, TPP1 possesses an OB fold that is able to recruit telomerase to telomeres, providing a link between telomerase and the shelterin complex. It is likely that the shelterin complex modulates the positioning of the TPP1-POT1 heterodimer at telomeres to either negatively regulate telomerase access to inhibit telomere elongation, or to enable TPP1-POT1 to serve as a telomerase processivity factor for telomere extension (Wang et al, 2007; Xin et al, 2007) .
Although the shelterin complex serves to prevent telomeres from being recognized as a DDR, paradoxically many DDR proteins localize to telomeres. Instead of recognizing telomeres as damaged DNA, these proteins appear to play a critical role for proper replication of telomeric DNA (Verdun et al, 2005; Verdun and Karlseder, 2007) . Central to the DDR are ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3 related) protein kinases (Zhou and Elledge, 2000) . ATM is involved primarily in sensing and responding to DSBs (Shiloh, 2003) , while ATR responds to lesions after they have been processed to single-stranded DNA intermediates (Zou and Elledge, 2003) . Once activated, ATM and ATR phosphorylate a range of factors including CHK1 and CHK2, which then target various effector proteins such as p53 to affect DNA repair, transcription and cell-cycle progression (Bartek and Lukas, 2003) . Recent evidence suggests that engagement of the DDR pathway is important for tumor suppression. While induction of p53-dependent apoptosis is clearly important for tumor suppression, we and others have recently shown that dysfunctional telomeres also activate a DDR response to initiate p53-dependent cellular senescence to inhibit tumorigenesis in vivo (Cosme-Blanco et al, 2007; Feldser and Greider, 2007) . However, it is unclear whether telomere dysfunctioninitiated DDR is capable of suppressing tumorigenesis in cells incapable of inducing cellular senescence/apoptosis due to loss of p53 function.
Although ATM is clearly involved in sensing and processing damaged signal from critically shortened telomeres or telomeres deficient in TRF2 (Karlseder et al, 1999; Herbig et al, 2004; Celli and de Lange, 2005; Verdun and Karlseder, 2006) , little is known about how telomeres activate ATR. ATR is recruited to telomeres during late S-phase, suggesting that it is required for telomere replication (Verdun and Karlseder, 2006) . Since POT1 specifically binds single-stranded telomeric G-overhang and is displaced during DNA replication (Verdun et al, 2005) , it is likely that POT1 functions to mask an ATR-dependent DNA damage checkpoint from the singlestranded overhang.
In this study, we demonstrate that mouse Tpp1 confers telomere end protection by recruiting Pot1a and Pot1b to telomeres. Stable knockdown of Tpp1 elicits an ATM-dependent DNA damage response at telomeres. In contrast to depletion of Trf2, removal of Pot1a and Pot1b from telomeres initiates an ATR-dependent DDR. Finally, we show that telomere dysfunction promotes chromosomal instability and tumorigenesis in the absence of ATM-dependent DDR. Our results uncover an ATR-dependent DDR at telomeres that is shielded by Pot1a and Pot1b binding to the single-stranded overhang, and reveal the biological consequence of telomere dysfunction in the setting of ATM deficiency.
Results

TPP1 confers telomere end protection by recruiting Pot1a and Pot1b to telomeres
In human cells, POT1 forms a heterodimer with TPP1 to modulate telomere structure and telomerase activity (Wang et al, 2007; Xin et al, 2007) . We have previously shown that murine Tpp1 interacts with the C-terminus of both Pot1a and In panels E and F, a minimum of 100 nuclei was scored, and error bars represent standard error of the mean (s.e.m). Pot1b Wu et al, 2006) . To further elucidate the role of Tpp1 at telomeres, we utilized RNAi knockdown of Tpp1 to determine its requirement for the localization of Pot1a and Pot1b to telomeres. Two independent shRNAs targeting Tpp1 were found to effectively reduce endogenous Tpp1 mRNA levels in mouse embryo fibroblasts (MEFs) as determined by RT-PCR ( Figure 1A ). Both Tpp1 shRNAs also significantly diminished the protein levels of exogenously expressed HA-tagged Tpp1 ( Figure 1A , and data not shown). Expression of Myc-tagged Pot1a or Flag-tagged Pot1b in MEFs showed their expected telomeric accumulation ( Figure 1B and C) . However, while highly expressed, both proteins failed to localize to telomeres in appreciable levels when Tpp1 is depleted ( Figure 1A-C) , consistent with recent reports that interactions of Pot1a/Pot1b with Tpp1 is required for proper localization to telomeres (Hockemeyer et al, 2007) .
Since both Pot1a and Pot1b play important roles in telomere end protection, knockdown of Tpp1 is predicted to reduce the accumulation of both Pot1 proteins at telomeres and render them incapable of forming protective structures. To examine this possibility, a Terminal deoxy-Transferase (TdT) assay that adds FITC-conjugated deoxy-uridine to naked telomere ends (Verdun et al, 2005) was used to probe telomeric structure in unsynchronized MEFs infected with vector or shTpp1. The TdT-FITC assay did not detect specific nuclear staining in vector-infected MEFs ( Figure 1E and F). In contrast, B95% of TdT signals colocalized with telomeres in B50% of TPP1 knockdown cells examined, indicating robust telomere uncapping ( Figure 1D-F) . A similar quantity of TdT signals colocalized with telomeres in Tpp1 knockdown, ATM À/À MEFs, indicating that functional ATM is not required to uncap telomeres ( Figure 1D-F) . This result suggests that telomeres cannot efficiently form a protective structure in the absence of Tpp1.
Knockdown of Tpp1 elicits a p53-dependent growth arrest Uncapped telomeres activate a DDR that, depending on cell type, impinges upon the p53 pathway to elicit apoptosis or cellular senescence (Karlseder et al, 1999; d'Adda di Fagagna et al, 2003) . To assess the effect of Tpp1 depletion on cellular proliferation, we treated early-passage primary MEFs with vector, shTpp1-1 or shTpp1-2, and monitored cell growth. Depletion of Tpp1 resulted in significant growth arrest, while little growth effect was observed in vector-infected MEFs ( Figure 2A ). Growth-arrested shTpp1 knockdown cells displayed a flattened morphology and a 10-fold increase in the number of senescence-associated (SA)-b-galactosidase-positive cells, a marker for cellular senescence ( Figure 2B and C).
Correlating with this decline in cellular proliferation was the observation of a threefold decrease in the number of 5-bromodeoxyuridine (BrdU) signals in Tpp1-depleted cells ( Figure 2D ). Importantly, the senescence phenotype observed in shTpp1-expressing cells was largely abrogated when a fulllength Tpp1 construct mutated to be resistant to shTpp1-mediated degradation was coexpressed, indicating that the Tpp1 hairpins utilized in our experiments indeed target endogenous Tpp1 ( Figure 1A) , suggesting that the presence of p53 is required to mediate growth arrest. Consistent with the observation that cells undergoing cellular senescence activate the p53-p21-mediated signaling pathway, knockdown of Tpp1 results in phosphorylation of p53 serine 18 and upregulation of the CDK inhibitor p21 ( Figure 2E ). Taken together, these results indicate that depletion of Tpp1 elicits the onset of p53-dependent cellular senescence.
Stable Tpp1 depletion and expression of Tpp1 mutants initiates an ATM-dependent DDR at the telomeres
Removal of the double-stranded telomere-binding protein TRF2 from telomeres initiates an acute telomere deprotection phenotype, resulting in the activation of the ATM kinase and a DDR manifested in part as increased phosphorylation of DNA damage proteins such as g-H2AX ( Figure 3A ; Karlseder et al, 1999) . To test whether depletion of Tpp1 initiates an ATM-dependent DDR, we monitored g-H2AX levels in ATM þ / þ and ATM À/À cells stably expressing vector or shTPP1. Phosphorylated g-H2AX and Chk2 accumulated in
( Figure 3B and C). To ascertain whether the DDR originated at telomeres, we utilized the telomere-dysfunction-induced foci (TIF) assay, which monitors the telomeric association of DNA damage proteins g-H2AX and 53BP1 (Takai et al, 2003) .
ited a minimum of five TIFs, whereas TIFs were observed in only B5% of the Tpp1-depleted ATM À/À cells ( Figure 3D and E; Supplementary Figure 1B ). This result indicates that longterm depletion of Tpp1 elicits a robust ATM-dependent DDR at telomeres. Among the six core proteins that bind telomeres, multiple pairwise interactions have been demonstrated to form a highorder telomeric complex that mediates telomere end -capping and length control. Previous observations indicated that TPP1 interacts not only with POT1 to form a complex that caps telomeres, but also with TIN2 to mediate proper sixprotein complex assembly (O'Connor et al, 2006; Xin et al, 2007) . Therefore, disruption of either TPP1-POT1 or TPP1-TIN2 interactions may result in deprotected telomeric ends to elicit a DDR at telomeres. To further probe which Tpp1 subcomplex is important for telomere end capping, we generated two Tpp1 mutants containing-domain specific mutations. The Tpp1 DRD mutant lacks the Pot1 recruitment domain and is predicted to disrupt only Tpp1-Pot1 interactions, while the Tpp1 DC mutant lacks the C-terminal half of Tpp1 and is able to eliminate the binding of Tpp1 to TIN2 but not to Pot1 ; Supplementary . Western analysis revealed that overexpression of Tpp1 Figure 3C ). TIF assays showed that expression of Tpp1 DRD and Tpp1 DC elicited a potent damage response at telomeres, with more than five TIFs in 70% ATM þ / þ cells, while the TIF signal was significantly reduced in ATM À/À cells ( Figure 3D -G). These results reinforce the notion that interaction of Tpp1with both Pot1 and Tin2 is essential to prevent telomere ends from being inappropriately recognized as DSBs to activate an ATM-dependent DDR.
Expression of mutant Tpp1 results in a DDR
at telomeres that is independent of ATR Although our data suggest that ATM is required for the DDR following stable Tpp1 depletion or expression of Tpp1 mutants, it is possible that the ATR kinase is also involved in this damage response. Depletion of Tpp1 resulted in a threefold increase in single-stranded telomeric DNA, which is independent of ATM status (Supplementary Figure 3) , and may therefore activate an ATR-dependent response. To test this possibility, we utilized E1-transformed ATR F/À MEFs (Brown and Baltimore, 2003) . In control experiments with aphidicolin treatment, Chk1 phosphorylation, a hallmark of ATR signaling, was markedly reduced when the floxed allele of ATR was deleted by adenoviral Cre-recombinase (AdCre; Figure 4A ). ATR F/À MEFs were infected with shTpp1, and then treated with either the empty adenoviral vector (AdE) or AdCre to generate Tpp1-depleted, ATR Ä /À MEFs ( Figure 4A , and data not shown). TIF analysis revealed that B40% ATR F/À cells and B35% ATR Ä /À cells in which Tpp1 was stably depleted have a minimum five TIFs ( Figure 4B-D 
Since there is no significant differences in TIF formation between ATR F/À and ATR Ä /À MEFs in which Tpp1 levels were perturbed by stable shRNA knockdown or overexpression of Tpp1 mutants, these results suggest that an ATR-dependent DDR is not induced by inactivation of endogenous Tpp1. These data further strengthen the notion that ATM plays a dominant function in sensing dysfunctional telomeres when Tpp1 containing protein complexes are disrupted.
Removal of Pot1a and Pot1b from telomeres initiates an ATR-dependent DDR
Pot1a and Pot1b specifically bind to single-stranded telomeric G-rich DNA, and deletion of both proteins results in a robust DDR at telomeres Hockemeyer et al, 2006 Hockemeyer et al, , 2007 Wu et al, 2006) . We have previously shown that deletion of Pot1a initiates an ATM-dependent DDR (Wu et al, 2006). However, this activation of ATM could be an indirect result of dicentric chromosome formation, which when resolved by the breakage-fusion-bridge (BFB) cycle could lead to the production of DNA DSBs that are sensed by ATM. Indeed, shRNA-mediated depletion of both Pot1a and Pot1b in ATM À/À MEFs still resulted in robust phosphorylation of g-H2AX ( Figure 5A ). The TIF assay showed that B40% Pot1a/Pot1b-depleted ATM þ / þ cells exhibited a minimum of five TIFs, with no significant difference in TIF formation observed when Pot1a and Pot1b were depleted in ATM À/À MEFs ( Figure 5B ; Supplementary Figure 4A and B).
This result suggests that ATM is not the primary sensor of a Pot1a/Pot1b-dependent DDR at telomeres. We postulated that removal of both Pot1a and Pot1b from telomeres would unmask the single-stranded G-overhang and activate an ATR-dependent DDR at telomeres. Previously, it has been shown that stalled DNA replication in ATR-knockout cells leads to increased g-H2AX phosphorylation and chromosome breaks (Brown and Baltimore, 2003) . This increase in g-H2AX phosphorylation is presumably the consequence of increased replication fork collapse in the absence of ATR and subsequent ATM/DNA-PK-dependent phosphorylation of g-H2AX (Rogakou et al, 1998; Burma et al, 2001 ). However, single-stranded DNA generated as a consequence of Pot1a/Pot1b reduction would not involve replication fork stalling; thus, the dependence of g-H2AX phosphorylation on ATR in response to Pot1a/Pot1b reduction could be assessed. To test whether depletion of Pot1a/Pot1b results in ATR-dependent g-H2AX phosphorylation, we knocked down both Pot1a and Pot1b in ATR 
ATR
Ä /À MEFs did not result in appreciable g-H2AX and Chk1 phosphorylation ( Figure 5C ). Furthermore, g-H2AX-positive TIF formation was substantially reduced in the absence of ATR (from 48% of cells with at least 5 TIFs to 8% and a reduction of 12 to three TIFs observed per cell; Figure 5D ; Supplementary Figure 4C and D) . In addition, we generated Pot1a Figure 5A and B) . These results suggest that loss of Pot1a is sufficient to unmask a novel ATR-dependent DDR at telomeres.
Since localization of Pot1a and Pot1b to telomeres depends critically upon Tpp1, we were surprised to find that stable depletion of Tpp1 initiated primarily an ATM-dependent DDR. We reasoned that long-term depletion of Tpp1 results in the formation of fused chromosomes, which when broken could initiate the BFB cycle to generate double-strand DNA breaks and subsequent induction of ATM (Hockemeyer et al, 2007) . To resolve this paradox, we treated ATM Telomere dysfunction promotes chromosomal instability and tumorigenesis in the absence of ATM-dependent DDR Activation of DDR genes such as ATM and ATR engage p53 to enforce cellular senescence, thereby preventing the proliferation of genetically damaged cells to suppress tumorigenesis (Bartkova et al, 2005) . However, would-be tumor cells that lose p53 function cannot engage apoptosis/cellular senescence pathways and therefore must be culled by other means. The prominent g-H2AX-positive TIFs observed in p53-null, ATM þ / þ MEFs in which Tpp1 is stably depleted, prompted us to speculate that long-term depletion of Tpp1 activates a persistent ATM-dependent DDR checkpoint to inhibit tumorigenesis in the absence of p53. To examine this possibility, Figure 6A , and data not shown). Telomere-FISH revealed a B5-fold increase in the number of chromosomal aberrations, including p-p arm fusions with telomeric DNA at the site of fusion, isochromatid rings characteristic of Pot1a deletion and tetraploid metaphases with diplochromosomes reminiscent of those observed in Pot1a/Pot1b double knockout cells ( Figure 6B ; Wu et al, 2006; Hockemeyer et al, 2006) . In addition to p-p arm telomere fusions, triple deleted cells contained a significant number of chromosome fusions without detectable telomeric DNA at the fusion site, which could be the consequence of engagement of the BFB cycle ( Figure 6B and C). Consistent with this possibility, anaphase bridges were observed with chromatin bridges containing telomeric signals (Supplementary Figure 6A and B) . In sharp contrast, no anaphase bridges and a marked reduction in the number of chromosomal abnormalities were observed in shTpp1-infected, ATM þ / þ , p53 À/À cells ( Figure 6C , and data not shown). These data suggest that loss of ATM promotes chromosomal instability in the setting of telomere dysfunction and p53 deficiency.
To investigate whether the elevated genomic instability in the triple deleted cells is able to initiate cellular transformation, we subjected triple deleted and shTpp1-1-infected, ATM þ / þ , p53 À/À cells to a soft-agar assay. Only triple deleted cells were able to grow in an anchorage-independent manner, and B10 foci were obtained in the two independent triple deleted cell lines ( Figure 6D and E). Next, we evaluated their ability to form solid tumor in vivo. Two independent triple deleted cell lines were injected subcutaneously into SCID mice and within 12 weeks; both cell lines gave rise to tumors ( Supplementary Figure 6C and D; Supplementary Table 1 ). In contrast, none of the three Tpp1 depleted, ATM þ / þ , p53 À/À cell lines formed tumor in SCID mice.
Furthermore, triple deleted tumors possess elevated genomic instability, with end-to-end chromosomal fusions, diplochromosomes and isochromatid rings resembling aberrations observed in Pot1a/Pot1b double knockout cells ( Figure 6F ; Supplementary Figure 6E and F; Hockemeyer et al, 2006) . Taken together, these data suggest that loss of ATM can cooperate with telomere dysfunction initiated by Tpp1 loss to promote cellular transformation and tumor formation in vivo in the setting of p53 deficiency.
Discussion
We have previously shown that Pot1a is required to protect telomeres from initiating a DDR and that the C-terminal domain of both Pot1a and Pot1b interacts with Tpp1 Wu et al, 2006) . In this report, we show that Pot1a and Pot1b require Tpp1 for localization to telomeres. Depletion of Tpp1 prevented Pot1a and Pot1b from localizing to telomeric DNA. In addition, shRNA-mediated knockdown of Tpp1 activates a robust DDR at telomeres, suggesting that Tpp1 plays a crucial role in preventing telomere ends from being recognized as damaged DNA. These results are consistent with recent observations that the interaction of POT1 with TPP1 is essential for complete telomere end protection (Hockemeyer et al, 2007; Xin et al, 2007) , and that POT1 and TPP1 are evolutionary conserved homologues of the Oxytricha nova TEBP-á and TEBP-b heterodimer (Wang et al, 2007; Xin et al, 2007) .
With respect to DNA damage-signaling pathway at telomeres, deletion of Pot1a is not functionally equivalent to loss of Trf2. While elimination of Trf2 initiates primarily an ATMdependent, ATR-independent DDR, removal of Pot1a results in a novel ATR-mediated DDR at telomeres. Since Pot1a and Pot1b both specifically bind single-stranded telomeric G-overhangs, and deletion of Pot1b results in rapid overhang elongation Hockemeyer et al, 2006; Wu et al, 2006) , it is likely that Pot1a and Pot1b cooperate to mask an ATR-dependent DNA damage checkpoint emanating from the single-stranded overhang. We speculate that a primary function of Pot1a and/or Pot1b is to prevent RPA from binding to telomeric overhangs to activate an ATRdependent DNA damage response (Figure 7 ). Several lines of evidence support this hypothesis. The OB fold of hRPA70 is predicted to bind tightly to telomeres, and therefore might compete with POT1 for binding to single-stranded telomeric DNA (Theobald et al, 2003) . RPA is also recruited to telomeres during DNA replication when POT1 is transiently released from telomeric DNA, suggesting that the two proteins could compete for the same DNA substrate (Verdun et al, 2005; Verdun and Karlseder, 2007) . Finally, ATR is potently activated by 5 0 ds/ssDNA junctions that resemble the telomere overhang (MacDougall et al, 2007) . We envisage a scenario in which loss of POT1 results in the coating of the single-stranded telomeric overhang by RPA, recruiting ATR/ ATRIP and additional factors such as Rad 17 and the 9-1-1 complex to telomeres (Figure 7; Zou, 2007) . Indeed, a role for the 9-1-1 complex has been found at telomeres, since deletion of Hus1, an integral component of this complex, results in severe telomere shortening (Francia et al, 2006) . Subsequent activation of ATR-ATRIP by the addition of TopBP1 and Claspin activates the kinase activity of ATR to phosphorylate Chk1 and the transduction of the damage signal to p53, where it initiates cellular senescence or apoptosis to prevent the proliferation of genetically damaged cells. While our manuscript was under review, similar results were reported by the de Lange laboratory, in which Trf2 and Pot1a function to independently repress the activation of ATM and ATR at telomeres (Denchi and de Lange, 2007) .
Removal of TPP1 results in rapid telomere elongation, presumably due to inability of POT1 to protect telomeric termini, allowing telomerase access (Kelleher et al, 2005; Lei et al, 2005; Wang et al, 2007; Xin et al, 2007) . Our results further show that loss of Tpp1 significantly reduced the accumulation of Pot1a and Pot1b at telomeres. While transient knockdown of Tpp1 initiates a robust ATR-dependent DDR, as was observed when Pot1a and Pot1b were depleted, long-term Tpp1 knockdown elicited primarily an ATM-dependent DDR. Although the molecular mechanism contributing to this difference in damage signaling is not yet clear, biochemical analysis suggest that TPP1 not only binds POT1, but also interacts with TIN2 to stabilize TRF1-TIN2-TRF2 interaction (O'Connor et al, 2006) . ChIP data further suggest that telomeric accumulation of TPP1, TIN2 and POT1 is dependent on TRF2 (Hockemeyer et al, 2007) . Long-term depletion of Tpp1 is thus predicted to disrupt not only Pot1a/ 1b interactions with the telomeric overhang, but also perturb Trf2 subcomplex assembly, eventually leading to the activation of an ATM-dependent DDR at telomeres. Since Tpp1 Ä RD primarily activate an ATM-dependent DDR, it likely disrupts not only Tpp1-Pot1a/Pot1b interactions but also affects other components of the shelterin complex such as Trf2.
Emerging data suggest that components of the DDR pathway are either mutated or deregulated during tumorigenesis. DDR factors including ATM, ATR, g-H2AX, 53BP1 and Chk2 are frequently activated in early precancerous lesions, but are often abrogated in malignant tumors (Khanna and Jackson, 2001; Bartkova et al, 2005; Gorgoulis et al, 2005; Nuciforo et al, 2007) . In oncogene-mediated cellular transformation, DNA replication stress including the accumulation of aberrant replication forks impinges upon ATM/ATR to activate p53-dependent cellular senescence to suppress tumorigenesis (Bartkova et al, 2005; Di Micco et al, 2006) . Elimination of ATM results in tumor progression, suggesting that ATMdependent DDR checkpoint constrains malignant progression by activating a senescence barrier. Selection of genome altering events, such as inactivation of p53 and other parti- Figure 7 Speculative model of how the shelterin complex represses ATM/ATR-dependent DDR at telomeres. We envision Pot1a as the main repressor of ATR, while ATM is mainly repressed by Trf2. Repression of ATR prevents the activation of Chk1 and p53, while ATM is required to prevent the accumulation of chromosomal breaks and subsequent genomic instability. NHEJ at telomeres is repressed mainly by Trf2, while aberrant telomere HR is repressed mainly by Pot1a/Pot1b. cipants in the DDR pathway, could potentially overcome this barrier. This notion is supported in mice with combined DDR and p53 deficiencies, in which increased chromosomal translocations cause accelerated tumor onset (Bassing et al, 2003; Celeste et al, 2003) .
We observed that reduction of Tpp1 initiates a persistent ATM-dependent DDR at telomeres in cells that bypassed cellular senescence due to p53 deficiency. Therefore, we propose that the ATM-dependent DDR plays important roles in preventing telomere dysfunction-initiated tumorigenesis independent of p53 function. Our data revealed that dysfunctional telomeres generated by depletion of Tpp1 potently induced tumor formation in the setting of both ATM and p53 deficiency. Tpp1-depleted ATM À/À and p53 À/À tumors possess elevated chromosomal aberrations, suggesting that random gains and/or losses of chromosomal segments may allow for the stepwise accumulation of genetic changes in favor of tumor progression (O'Hagan et al, 2002) . Loss of ATM appears to favor the formation of chromosomal translocations, since broken chromosomes persist when ATM is deleted (Callen et al, 2007) . This reservoir of translocationcompetent chromosomes would be predicted to fuel rampant genomic instability and the selection of cancer-relevant pathways, as is evident in lymphomas derived from ATM À/À and p53 À/À mice with dysfunctional telomeres (Maser et al, 2007) . Our results support a speculative model in which telomere dysfunction induced by loss Pot1a elicits primarily an ATRdependent DDR, whereas long-term depletion of Tpp1 elicits primarily an ATM-dependent DDR to activate p53-mediated cell senescence or apoptosis to inhibit tumorigenesis (Figure 7 ). In the setting of p53 deficiency, the ATM-dependent DDR prevents tumor initiation by suppressing the generation of persistent chromosomal breaks (Callen et al, 2007) . Together, these findings highlight a plausible role for ATM/ ATR-mediated DDR in suppressing the genesis of chromosomal instability-driven carcinomas, and suggest that tumors initiated by dysfunctional telomeres might be refractory to therapeutic strategies based on inhibition of the DNA damage pathways.
Materials and methods
Vectors, cell lines and antibodies
Retrovirus expression constructs for Pot1a and Pot1b were described . Based on cDNA gi:22823923 (Liu et al, 2004a) , we used RT-PCR strategy to clone mouse Tpp1cDNA in frame with a 5 0 HA epitope tag at the N-terminal, and the fragment was inserted into the BamHI and EcoRI sites of retroviral vector pQCXIP (Novex). To obtain retrovirus expression construct of Tpp1 DRD (residues 1-161 plus 255-416), an NheI mutation site was introduced when residues 162-254 of Tpp1 were deleted. The retroviral expression vector pQCXIP-Tpp1 DC (residues 1-255) was constructed by removing the C-terminal residues 256-416 of Tpp1. The sequences of primers for all constructs described are available upon request. All constructs were verified by DNA sequencing.
ATR F/À and p53
À/À MEFs were generated as described (Brown and Baltimore, 2003; Wu et al, 2006) . To generate ATR D/À MEF, ATR F/À MEFs were infected with AdCre at an MOI of 200. Deletion of ATR was confirmed by RT-PCR and Western analyses. All the primary MEFs were maintained in DMEM supplemented with 10% fetal bovine serum and cultured under 3% oxygen to minimize premature entry into senescence (Parrinello et al, 2003) . Antibodies used are as follows: phospho-p53 ser15 (no. 9284), phospho-ATM Ser 1981(no. 4526) and phospho-CHK1 (no. 2341) from Cell Signaling; Chk2 (no. 611570) from BD Biosciences; p21(Sc-6246) from Santa Cruz; g-tubulin, HA, Flag and Myc from Sigma; ATR (PC538) from Calbiochem; gH2AX (no. 05-636) from Upstate; anti-53BP1 was a kind gift from Phil Carpenter, UTHMB; and antibodies against mouse TRF1 and TRF2 were kind gifts from Dr Karlseder, Salk Institute.
RNA isolation, RT-PCR and shRNA interference RNA was isolated from approximately 10 6 cells with the Qiagen RNAeasy kit. RT-PCR was performed with the oligo-dT RT-PCR system according to the protocol provided by Invitrogen. Two shRNA against Tpp1s were generated in pSuper as described (Deng et al, 2003) . To generate pRetro-Super constructs, EcoRI-and XhoIdigested insert from pSuper was subcloned into the same site into pRetro-Super vector (Brummelkamp et al, 2002) . The shRNA target sequences for mouse Tpp1 is shRNA-Tpp1-1, 5
0 -TCAGGATTCAG ATGTGCAG-3 0 ; shRNA-Tpp1-2 and 5 0 -GCTGTGTTCACTGTGTCTG-3 0 . The target sequence of shRNA-Tpp1-2 was changed to 5 0 GCTGTCTTCACGGTCT CTG-3 0 by standard site-directed mutagenesis to create shRNA-TPP1-2-resistant construct pRetro-Super shTPP1-2-M, according to the manufacturer's recommended protocol (Stratagene).
Retroviral infections and shTPP1-knockdown cell lines
To generate retroviruses, 10-cm dishes of 293 Phoenix packaging cells were transfected with 5 mg each of the Tpp1 mutants (Tpp1 DRD or Tpp1 DC ), pSuper-Retro-shTpp1 or retroviral control vector using Lipofectamine (Invitrogene). Viral supernatants were harvested 24 h after transfection and used to infect fibroblasts with 8 mg/ml polybrene. Fresh medium was added to the packaging cells and 12-18 h later viral supernatants were collected a second time to super-infect the fibroblasts with 8 mg/ml polybrene. To obtain shPot1a-and shPot1b-knockdown cells, cells were first infected by shPot1a viral supernatants; after 6 h the cells were infected again by shPot1b viral supernatant. To obtain shTpp1-knockdown cells, drug selection of retrovirally transduced cells was started 48 h after the second infection by supplementing the culture medium with puromycin at 2.5 mg/ml final concentration. All cells were deemed transiently knocked down when selected for 4 days, and stably knocked down when selected for 3 weeks.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
